MedTech companies often have meaningful developments to communicate, but the same story rarely works for physicians, customers, investors, employees, partners, and journalists. Clinical, technical, regulatory, and commercial context need to be translated without losing accuracy or relevance. Good PR gives each audience the context it needs to understand what changed and why the development matters.
Effective public relations for medical device companies can help:
Medical Device Public Relations Services
Build a communications roadmap around launches, milestones, partnerships, executive initiatives, events, clinical activity, market developments, timing, audiences, messages, media targets, approvals, and amplification.
Develop media angles, identify relevant trade, MedTech, healthcare, business, podcast, newsletter, local, or regional outlets, prepare pitches and supporting materials, coordinate outreach, and prepare spokespeople for interviews.
Develop medical device press releases and supporting communications around launches, regulatory milestones, clinical developments, partnerships, acquisitions, facilities, leadership appointments, financing, awards, and other substantive news.
Turn the perspective of executives, clinicians, engineers, product leaders, and other SMEs into contributed articles, interviews, LinkedIn content, speaking support, video, Q&As, bylines, and other credible thought leadership.
Connect PR with website updates, social content, email, video, sales enablement, event communications, executive messaging, and other channels surrounding product launches, conferences, clinical milestones, partnerships, and major developments.
We build communications around what happened, why it matters, who needs to understand it, and what information supports the story.
Different developments require different stories, audiences, and communication sequences.
Product Launches & Regulatory Milestones
Translate product introductions, clearances, approvals, new indications, clinical milestones, availability, and geographic expansion into communication the intended audience can understand.
Partnerships, M&A & Corporate Growth
Coordinate the narrative, stakeholder communication, press announcement, executive messaging, media outreach, and supporting content around acquisitions, partnerships, facilities, investments, and growth.
Executive & Thought Leadership
Build visibility around leaders and experts who can speak credibly about the company's technology, market, clinical category, manufacturing expertise, commercialization experience, or industry developments.
Trade Shows & Industry Events
Support pre-show announcements, media outreach, executive interviews, onsite content, product news, speaker promotion, event recaps, and post-show communication.
Not every company update is automatically newsworthy. Effective medical device media relations starts by evaluating whether the development creates enough relevance for an outside publication and its audience.
We look at:
An important announcement often contains more useful material than the press release alone can capture. Planning the surrounding communication at the same time helps teams reuse approved research, interviews, messaging, and creative instead of rebuilding the story for each channel. The story remains consistent while the format and level of detail change for each audience and channel.
The communications ecosystem can include:
A MedTech communications program designed around the developments, expertise, audiences, and business priorities the market needs to understand.
Communications Strategy
PR roadmap, story identification, audience planning, messaging architecture, media strategy, communication priorities, and campaign timing.
Media & Press Materials
Press releases, media pitches, journalist targeting, background materials, FAQs, media kits, interview preparation, and supporting information.
Executive & Thought Leadership
Executive interviews, contributed content, LinkedIn thought leadership, bylines, speaking support, Q&As, expert commentary, and content development.
Integrated Assets & Measurement
Website, social, email, sales, video, event, and newsroom extensions alongside coverage quality, referral traffic, search visibility, engagement, and future recommendations.
MedTech announcements can involve more reviewers than a typical corporate communications program. Product, clinical, transaction, patient, and physician communications may each require different approvals, permissions, and release timing. Icovy works within the communication and review process established by each client.
Planning can account for:
Connect PR strategy, media relations, press releases, executive thought leadership, product and corporate announcements, event communications, owned content, and measurement around the developments your market needs to understand.
Questions MedTech teams often encounter when evaluating media relations, corporate communications, product announcements, thought leadership, and a medical device PR agency.
A medical device PR agency helps companies determine which stories should be communicated publicly, how those stories should be positioned, which audiences need to hear them, and which channels are appropriate. The work may include PR strategy, media relations, press releases, product announcements, executive communications, thought leadership, interview preparation, event communications, contributed articles, newsroom content, and integrated campaign support. Medical device communications can also require coordination with regulatory, medical, legal, clinical, quality, investor, and executive teams depending on the subject. An agency working in MedTech should be comfortable developing communication within those constraints.
The subject matter is often more technical and the consequences of imprecise communication are higher. A MedTech PR agency may need to understand clinical evidence, regulatory status, intended use, product terminology, manufacturing, physician audiences, hospital buyers, investors, and the difference between what is commercially interesting and what the company can substantiate publicly. That does not mean every press release needs to read like a technical document. The agency needs enough subject knowledge to determine which details matter, ask the right questions, and translate complex developments accurately for different audiences.
A press release is most useful when the company has information that is genuinely relevant to customers, industry stakeholders, journalists, investors, partners, or the broader market. Examples may include product launches, regulatory milestones, clinical developments, acquisitions, financing, strategic partnerships, executive appointments, major manufacturing expansions, geographic growth, significant customer milestones, awards, or other substantive corporate developments.Routine internal activity does not necessarily require a press release. Icovy can help determine whether an announcement should receive a formal release, targeted media outreach, owned communications, social support, or a smaller communications effort.
No credible PR agency should guarantee independent editorial coverage. Journalists and publications determine which stories they cover, and those decisions depend on editorial relevance, timing, available space, existing relationships, competitive news, and the strength of the story itself. Icovy can improve the quality of the pitch, identify appropriate outlets, prepare the company for media engagement, build relationships, and develop stronger supporting materials. We cannot control an independent publication’s editorial decision.That distinction is important when evaluating PR performance.
We look at the development from the perspective of the publication and its audience. A company may be excited about an internal milestone that has little relevance outside the organization. Another development may initially appear routine but reveal a stronger story once the market impact, clinical relevance, customer problem, or industry context is understood. The evaluation usually considers what changed, who is affected, why the development matters now, what evidence supports the significance, and whether a credible subject-matter expert can add useful perspective. Sometimes the recommendation will be to communicate the development through owned channels instead of pursuing earned media.
PR can help establish context around the product before and during commercialization. The communications strategy may include the launch announcement, company and product messaging, executive quotes, media outreach, interview preparation, website updates, social content, launch video, HCP or customer communications, trade show activity, and follow-up thought leadership. For newer treatment or technology categories, journalists may also need enough background to understand the problem before the product itself makes sense. This is where PR can connect directly with product launch, HCP marketing, demand generation, content, sales enablement, and other commercialization work.
The communication needs to reflect the specific regulatory status accurately. Terms such as clearance, approval, authorization, designation, submission, and acceptance have different meanings and should not be used interchangeably. Product claims and indications also need to remain consistent with the information the company is authorized to communicate. Icovy develops communications within the regulatory and legal review process established by the client and works from approved product information. The story can still be compelling without overstating what the regulatory milestone means.
Executive thought leadership works best when the individual has a legitimate perspective on a subject the market cares about.Icovy can conduct interviews with executives and subject-matter experts, identify topics connected to their experience, and develop those ideas into contributed articles, media commentary, LinkedIn content, videos, interviews, speaking support, or other formats. The executive does not need to become a full-time content creator. A structured process can capture expertise efficiently while giving the leader enough involvement to ensure the material reflects how that person actually thinks and communicates.
PR generally focuses on proactive external communication, media relations, announcements, thought leadership, and the stories a company wants to bring into the market. Reputation management takes a wider view of how the company is perceived across search, reviews, social conversations, media, executive visibility, employee commentary, owned content, and other public sources. The two services frequently intersect. A reputation issue may require PR support. A strong PR program can also contribute positively to the body of credible information available about the company over time.
Planning should begin before the company arrives at the event. If there is a product announcement, partnership, executive interview opportunity, speaker session, company milestone, or other legitimate news angle, media outreach can begin in advance. During the event, PR may support interviews, executive content, onsite announcements, photography, video, social communication, and media coordination. Afterward, the company can extend relevant interviews, presentations, news, video, and market observations through follow-up communications rather than allowing the event to become a three-day isolated activity.
PR can generate visibility and third-party credibility, while content marketing gives the company more space to explain its expertise and point of view in depth. A media interview may lead to an executive article. A product announcement may create opportunities for technical content, videos, FAQs, email, or sales materials. A thought-leadership program may support both contributed media and the company’s owned content strategy.Coordinating the two helps the company make better use of the research, interviews, approvals, and ideas already required to produce the original communication.
Measurement should reflect the objective of the program.Relevant indicators may include coverage quality, outlet relevance, message pull-through, share of voice, referral traffic, branded search activity, executive visibility, media relationships, audience engagement, backlinks, or the performance of supporting content. Raw placement counts can be misleading. One substantive feature in a publication read by the company’s priority customers may carry more strategic value than dozens of low-relevance syndications.For larger integrated programs, PR can also be evaluated alongside website activity, search performance, campaigns, events, and other signals surrounding the announcement.
A specific announcement can create activity quickly if the story is timely and relevant.Building consistent media relationships, executive visibility, and market recognition usually takes longer. Journalists become more familiar with companies that communicate useful information consistently, provide credible experts, respond reliably, and understand what belongs in an editorial conversation. The appropriate timeline depends on how much existing visibility the company has, how often genuine news occurs, the strength of the available stories, and the publications or audiences being targeted.
When evaluating a medical device public relations agency or MedTech PR agency, look beyond the size of the agency’s media database. The team should understand your technology well enough to identify the meaningful story, ask informed questions, develop accurate messaging, work with subject-matter experts, and coordinate with internal review teams. It should also understand how PR connects with the rest of the commercialization strategy. Product launches, executive communication, HCP education, trade shows, SEO, content, social media, sales, and reputation frequently intersect with the same announcement. Icovy approaches communications within that larger MedTech marketing environment, allowing the PR strategy to support the business activity surrounding the story rather than ending once a release has been distributed.